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Introduction: The collaboration between palliative care and neurology has developed over the last 
25 years and this study aimed to ascertain the collaboration between the specialties across Europe. 
Methods: This online survey aimed to look at collaboration across Europe, using the links of the 
European Association for Palliative Care and the European Academy of Neurology. 
Results: 298 people completed the survey – 178 from palliative care and 120 from neurology from 
over 20 countries across Europe. They reported that there was good collaboration in the care for 
people with amyotrophic lateral sclerosis and cerebral tumours but less for other progressive 
neurological diseases. The collaboration included joint meetings and clinics and telephone contacts.  
All felt that the collaboration was helpful, particularity for maintaining quality of life, physical 
symptom management, psychological support and complex decision making, including ethical issues.  
Discussion: The study shows evidence for collaboration between palliative care and neurology, but 
with the need to develop this for all neurological illness, and there is a need for increased education 




Although palliative and hospice care is often associated with care of people with cancer, the role of 
palliative care in the care of people with progressive neurological disease has been increasingly 
adopted over the last 25 years, particularly amyotrophic lateral sclerosis / motor neurone disease 
(ALS/MND). Studies showed the many issues and symptoms experienced by ALS/MND patients could 
be managed effectively so that the majority of patients died peacefully [1,2]. 
More recently the European Association for Palliative Care (EAPC) and the European Academy of 
Neurology (EAN) collaborated in producing a Consensus Paper on neurological palliative care [3]. 
This outlined the main areas for collaboration: early involvement of palliative care, symptom 
management, carer support, communication and advance care planning, multidisciplinary team 
approach, end of life care including recognition of this phase, and education and training of 
professionals in both palliative care and neurology [3]. In the USA there has been development of 
Neuro-palliative care, with the additional training of neurologists who can then provide the fuller 
holistic approach [4,5]. 
The collaboration between palliative care and neurology has been studied to a limited extent. A UK 
survey showed that there were regular contacts between services for ALS/MND care – with 23% 
having regular contact with neurology services and 36% having contact with the MND Association 
[6]. The OPTCARE Neuro survey in the UK showed that, even in the centres which were about to 
undertake a trial intervention, the collaboration between the specialities was reported as 
good/excellent by only 36% of neurology and 58% of palliative care professionals [7]. Other studies 
have shown the benefits of multidisciplinary team working, with improvement in length of life for 
ALS/MND patients [8]. Moreover, guidelines have suggested increased palliative care involvement 




However, the number of people with progressive neurological disease receiving palliative care 
remains small.  In the UK only 1.2% of surveyed neurological patients had contact with a palliative 
care team [15] whereas 88% of cancer patients have contact with palliative care during the disease 
progression [16].  Moreover, 5% of deaths of neurological patients are in a hospice and 18% at 
home, compared to 16% of cancer patient deaths in a hospice and 29% at home [17]. 
This study aimed to build on the collaboration between the EAPC and EAN to ascertain the level of 
collaboration between neurology and palliative care services by using an online survey of 
practitioners across Europe. 
 
Methods 
An online survey was produced asking about the country of the person, their involvement with 
different disease groups, collaboration with the other discipline and their assessment of their 
competence in providing palliative care for people with neurological disease. There were two 
versions – for neurologists and for palliative care physicians – with appropriate differences according 
to the discipline. 
Details of the survey were circulated to the membership of the EAPC and EAN. Members of the EAPC 
Reference Group on Neurology and the EAN Speciality Group on Palliative Care were also provided 
with the details and asked to disseminate among their contacts. Members of both groups, and the 
EAPC and EAN, were asked to circulate to their membership. This was repeated after one month and 
a total of two months was allowed for completion. Additionally, the Italian Society for Palliative Care 
(SICP) and the Italian Society of Neurology (SIN) both advertised the survey among their 
membership. The potential number of people who would have had access to the survey is unclear, 
as the circulation was by highlighted on the EAN and EAPC websites - the EAN represents 47 national 
associations and the EAPC has 60 national associations with large memebrships.  There was also 
targeted circulation to their special interest groups on palliative care - EAN Specialty Panel on 
palliative care has 25 members and the EAPC Reference Group on Neurology has 40 contacts.  
Ethical approval for the study was obtained from the Ethics Committee of the Tizard Centre at the 
University of Kent, Canterbury, UK.  At the start of the survey there was an explanation of the 
purpose of the study and how data would be handled. Continuation of the questionnaire was taken 
to show consent but participants could stop at any time if they wished. 
The online survey was undertaken with SmartSurvey and a full analysis of the answers and the free 
text was available at the end of the survey period.  The free text responses were analysed by two 
independent observers (DJO and NH) and the themes extracted. 
 
Results 
661 people responded to the survey with 298 (45%) completed responses. Of these 178 were 
palliative care professionals from 14 countries, with a mean experience of 11.7 years, and 120 were 
neurologists from 20 countries, with a mean experience of 19.2 years. The commonest countries 
involved were: Italy (71 neurology and 142 palliative care; UK 9 / 9; Belgium 8 / 5; Croatia 0 / 6 ).  
Their place of work of palliative care specialists was primarily in inpatients units, either hospice 
(68%), community (76%) and out-patients (52%). Neurologists were involved in hospital (67%), 




The participants were members of wider team and the other disciplines within their teams are 
shown in Table 1. Although these teams were multidisciplinary, occupational therapy and speech 
and language therapy were less often within palliative care teams, and occupational therapy, social 
care and spiritual care were less often represented within neurology teams. 
The neurological diseases where there was felt to be collaboration between the teams are shown in 
Table 2. Cerebral tumour and ALS/MND were the most common diseases with collaboration and for 
Huntington’s disease, cortico-basal syndrome and myopathies there was the least collaboration.  
The methods of collaboration are shown in Table 3. The commonest collaboration was by regular 
telephone contact and joint clinics. Regular meetings, such as multidisciplinary meetings involving 
both areas, were uncommon. 
Barriers to collaboration identified by palliative care professionals included the reluctance of 
neurologists to refer patients to them (43%), financial or resource issues (20%) and the wish of 
family doctors to continue care so that they not involve them (17%).  Only 15% of the palliative care 
professionals identified patient reluctance or refusal as a barrier.  There were no comments added 
by participants. 
Neurologists also identified barriers to collaboration, including the lack of palliative care services in 
their area (28%), palliative care services not accepting referrals for patients with neurological disease 
(14%), and financial or other resource issues (43%). Patient reluctance or refusal to see a palliative 
care team was viewed to be rare – 10%. 
The main areas felt to be important for collaboration by both groups are shown in Table 4. There 
was general agreement that the most important areas where palliative care would be beneficial 
were supporting quality of life, caregiver support, psychological support and complex decision 
making. Advice on financial issues was felt to be of a lesser priority, although this was seen as more 
important within palliative care services. 
The self-assessment of their expertise did show that there were concerns. Only 18% of palliative care 
professionals felt that they had expert or very good knowledge of neurology and 44% stated that 
their expertise was none, limited or somewhat. 16% of neurologists stated that their expertise in 
palliative care was very good or expert and 57% stated that their expertise was none, limited, or 
somewhat.   
 
Discussion 
This survey shows that there is evidence of collaboration between palliative care specialists and 
neurologists across Europe. Moreover, this collaboration is seen as useful and helpful, particularly 
for areas that are complex in nature or require greater psychosocial support for patients and 
families. However, the main areas of collaboration are for cerebral tumours and ALS/MND with 
some collaboration for PD, MS, dementia and stroke, and little contact for Huntington’s disease (HD) 
or myopathies. This may reflect differences in the understanding of probable prognosis of these 
diseases – as ALS and cerebral tumours may have a shorter prognosis and a clearer trajectory of 
deterioration compared to the longer, and often uncertain pattern, of deterioration for patients with 





The team approach would seem to be apparent in both areas, although there are differences. 
Palliative care teams are less likely to have speech and language therapists, which may be very 
important in the assessment of many patients with progressive neurological disease, who frequently 
have speech impairment or swallowing problems. Neurology teams have less social and spiritual 
support and this may be reflected in the neurologists seeing palliative care as providing this 
increased support for patients and families. 
 
There are some barriers to this collaboration, although it would seem that patient and family 
reluctance to meet palliative care teams is not a major area of concern [18]. There may be 
differences across Europe in the availability of palliative care, especially teams who are involved with 
neurological disease. Although there is increasing interest in neurology, palliative care services may 
be reluctant to see people with progressive neurological disease due to concerns of staff of potential 
large numbers of patients who could be seen, and the pressure on resources. Other issues that 
increase this reluctance may be the trajectory of disease progression and prognosis being very 
variable – from months to years, with varying caring needs over these periods of time - the difficulty 
in identifying a dying phase, complexity of assessment and care, and the difficulties in accessing 
community services and equipment [19]. There are specific issues associated with the care of 
neurological disease including the variable timelines of progression, communication barriers, threats 
to personhood due to functional and cognitive change, and existential distress due to loss of 
autonomy, disability and fears of dying and death [20]. Financial and resource implications for 
collaboration will vary between countries and may need to be addressed locally.  
The results also suggest that there may be reluctance on the part of neurologists to refer patients for 
palliative care. Many neurologists may be reluctant to discuss the diagnosis of a progressive disease 
or the possible deterioration [21]. There may be reluctance to discuss possible complications and the 
likely prognosis, including discussion of the likelihood of death [22].  This is despite evidence that 
good communication, with an empathic approach, is appreciated by patients and families [23] and 
the provision of information in a timely way, allowing an awareness of prognosis, may help in 
decision making and reduce patient anxiety [24].  
The knowledge of both palliative care doctors and neurologists would seem to be an issue. This has 
been raised for many years and in 1996 the American Academy of Neurology Ethics and Humanities 
Subcommittee, in the USA, suggested that the principles of palliative care “are relevant to the 
management of almost all patients” [25]. Over 20 years ago research in the USA suggested that 
“neurologists have a duty to provide adequate palliative care” and made recommendations for the 
care of patients, in particular the ethical and legal issues of refusal of life sustaining treatment [26]. 
The need for education of neurologists in palliative care was emphasized in the care of dying 
patients, as it was found that many neurologists were very unclear about the ethical issues of 
withdrawing and withholding treatment and using analgesics at the end of life [21]. A recent online 
survey of consultants and residents in neurology in the Netherlands showed that discussions about 
these issues of withholding and withdrawing interventions or medication were often late in the 
disease progression in PD and MS but earlier in ALS and glioma [27]. Moreover, 75% of residents and 
64% of consultants had received education and training in the discussion of these issues [27]. In 
2014 it was found that in only 52% of training institutions included lectures on end of life care and 
palliative care and only 8% offered a clinical rotation in palliative care for neurologists [22].  
Although there is evidence of increasing collaboration for cerebral tumours and ALS/MND the other 
progressive neurological diseases are largely ignored. There is increasing evidence of an important 
role for multidisciplinary team care and palliative care for neurological patients, with evidence of 




16week multidisciplinary palliative care intervention, using a waiting list method, did show that 
there were improvements in quality of life, and symptoms – pain, breathlessness, bowel issues and 
sleep [28].  This trial included ALS/MND, MS and PD and related diseases.  Other Phase II trials have 
shown that short term palliative care interventions in for MS patients improved symptoms and 
caregiver burden in the group receiving palliative care, whereas there was deterioration in the 
control group [12]. The involvement of specialist nurses, who had received extra training in palliative 
care and support, was shown to reduce symptom burden but had no effect on quality of life or other 
outcomes [29].  
 
The educational needs of both specialties were addressed in the EAN/EAPC Consensus Paper, which 
recommended education and training for both specialties in the other area of care. Palliative care 
services may also have limited knowledge of the specific issues of people with neurological disease 
and the availability and effectiveness of interventions and medications [3]. There may be little 
education in palliative care principles for neurological teams (neurologists in training and continuing 
medical education for those in practice) involved in care. There may also be a need for all professionals 
to be trained in communication skills, when coping with these complex issues, particularly when faced 
with variable cognition. 
There are limitations to an online survey such as this. The respondents were those who had received 
or seen details of the survey within the communication outlets of the EAPC and EAN. This may bias 
the respondents to those with a particular interest in palliative care and neurology.  Moreover, there 
was a large response from Italian neurologists, who responded more enthusiastically to the request 
for involvement in the study from the Italian Society of Neurology and the Italian Society of Palliative 
Care.  This may have biased the figures, and a separate publication is planned looking at these Italian 
responses. However, there were responses from many different countries and the results may reflect 
an overall impression of the collaboration across Europe. This survey was limited to adult palliative 
care whereas the prevalence of neurological impairment in the paediatric population is higher, with 
reports of up to 75% [30]. The collaboration for this paediatric group is an area for further study.   
This study shows some evidence of collaboration for some chronic progressive neurological disease 
but also a need for increased education and collaboration for all progressive disease groups, 
associated with severe disability and reduced life expectancy. There is increasing interest in 
developing collaboration including the use of triggers for referral [31], joint and close working in out-
patient clinics [32], telemedicine [33] and the development of “neuro-palliative care” – with increased 
training of neurologists who could provide the ongoing care of patients with progressive neurological 
disease (4,5).  Further research is needed to build an evidence base showing the effectiveness of 
palliative care in neurology and to ascertain the best model for this interaction.  
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Table 1 Multidisciplinary team members 
           Palliative care        Neurology 
Doctor      90%    94% 
 Nurse      98%    99% 
 Psychologist     90%    79% 
Physiotherapist     77%    79% 
 Social worker     73%    53% 
Spiritual care     61%    43% 
Occupational Therapist    27%    43% 




Table 2 Collaboration for different neurological diseases 
     Palliative care    Neurology 
                       Strong / Strong+moderate/ None       Strong / Strong+moderate/ None 
 
 Cerebral tumour 36%  68%     13%            33% 63%  20% 
ALS   31%  63%    14%           45% 70%               10% 
Dementia  14%  30%    24%            9% 39%               25% 
Stroke   13%  34%     31%            12% 36%               31% 
 MS   8%  34%    31%            9% 37%               30% 
PD   7%  30%    27%           5% 27%               38% 
 MSA   3%  20%    45%           7% 32%               42% 
 PSP   3%  17%    49%           7% 31%               41% 
 HD   4%  14%    62%            7% 36%               35% 
 CBD   3%  14%      62%             5% 26%  42% 







Table 3 Modes of collaboration 
          Palliative care        Neurology 
Joint Out-patient Clinics    29%    24% 
 Multidisciplinary Team meetings  25%    29% 
 Informal Meetings    20%    21% 
Ward rounds     15%    13% 
 Telephone calls     50%    50% 
 
Table 4 Areas where collaboration would be considered to be useful or expected  
           Palliative care        Neurology 
 
Quality of life     99%    85% 
Physical symptoms    94%    74% 
 Psychological support    96%    77% 
 Complex decision making   96%    76% 
Information     97%    68% 
Caregiver Quality of life    94%    83% 
 Caregiver anxiety    95%    74% 
 Advance care planning    90%    71% 
Practical problems    86%    68% 
Coordination of care    75%    60% 
Hospital admission    61%    60% 
 Finances     43%    26% 
  
  
  
